T-cell NHL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors (NCT02071888) | Calithera Biosciences, Inc | 2014-02-01 |
Track T-cell NHL automatically
Every clearance here is in the API, with alerts when new ones post.